Cargando…
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
Mesenchymal stromal cells (MSCs) are increasingly used in regenerate medicine. Placenta-derived decidual stromal cells (DSCs) are a novel therapy for acute graft-versus-host-disease (GVHD) and hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (HSCT). DSCs are more im...
Autores principales: | Baygan, Arjang, Aronsson-Kurttila, Wictor, Moretti, Gianluca, Tibert, Babylonia, Dahllöf, Göran, Klingspor, Lena, Gustafsson, Britt, Khoein, Bita, Moll, Guido, Hausmann, Charlotta, Svahn, Britt-Marie, Westgren, Magnus, Remberger, Mats, Sadeghi, Behnam, Ringden, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504152/ https://www.ncbi.nlm.nih.gov/pubmed/28744284 http://dx.doi.org/10.3389/fimmu.2017.00795 |
Ejemplares similares
-
Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018) -
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022) -
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020) -
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020) -
Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
por: Sadeghi, Behnam, et al.
Publicado: (2022)